124 related articles for article (PubMed ID: 17948195)
1. [Transarterial chemoperfusion with gemcitabine and mitomycin C in pancreatic carcinoma: results in locally recurrent tumors and advanced tumor stages].
Vogl TJ; Zangos S; Heller M; Hammerstingl RM; Böcher E; Jacob U; Bauer RW
Rofo; 2007 Nov; 179(11):1181-8. PubMed ID: 17948195
[TBL] [Abstract][Full Text] [Related]
2. [Transarterial chemoperfusion of the pelvis--results in symptomatic locally recurrent tumors and lymph node metastases].
Vogl TJ; Zangos S; Eichler K; Balzer JO; Jacob U; Keilhauer R; Bauer RW
Rofo; 2007 Nov; 179(11):1174-80. PubMed ID: 17805998
[TBL] [Abstract][Full Text] [Related]
3. [Transarterial chemoperfusion of inoperable pancreas carcinoma and local recurrence].
Vogl TJ; Heller M; Zangos S; Schwarz W; Eichler K; Mack MG; Berger D; Balzer JO
Rofo; 2003 May; 175(5):695-704. PubMed ID: 12743865
[TBL] [Abstract][Full Text] [Related]
4. Locoregional/systemic chemotherapy of locally advanced/metastasized pancreatic cancer with a combination of mitomycin-C and gemcitabine and simultaneous follow-up by imaging methods and tumor markers.
Klapdor R; Seutter E; Lang-Pölckow EM; Reichle H; Hinrichs A
Anticancer Res; 1999; 19(4A):2459-69. PubMed ID: 10470175
[TBL] [Abstract][Full Text] [Related]
5. Nonselective transarterial chemoperfusion: a palliative treatment for malignant pleural mesothelioma.
Vogl TJ; Lindemayr S; Naguib NN; Gurung J; Nour-Eldin NE; Zangos S; Mbalisike EC
Radiology; 2013 Feb; 266(2):649-56. PubMed ID: 23151824
[TBL] [Abstract][Full Text] [Related]
6. Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine.
Kornek GV; Pötter R; Selzer E; Schratter A; Ulrich-Pur H; Rogy M; Kraus G; Scheithauer W
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):665-71. PubMed ID: 11172947
[TBL] [Abstract][Full Text] [Related]
7. Retrospective study on the use of different protocols for repeated transarterial chemoembolization in the treatment of patients with hepatocellular carcinoma.
Vogl TJ; Naguib NN; Nour-Eldin NE; Farshid P; Lehnert T; Gruber-Rouh T; Engels KS
Acad Radiol; 2012 Apr; 19(4):434-9. PubMed ID: 22265853
[TBL] [Abstract][Full Text] [Related]
8. Palliative hepatic intraarterial chemotherapy (HIC) using a novel combination of gemcitabine and mitomycin C: results in hepatic metastases.
Vogl TJ; Zangos S; Eichler K; Selby JB; Bauer RW
Eur Radiol; 2008 Mar; 18(3):468-76. PubMed ID: 17938935
[TBL] [Abstract][Full Text] [Related]
9. Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancer.
Lee S; Oh SY; Kim BG; Kwon HC; Kim SH; Rho MH; Kim YH; Rho MS; Jeong JS; Kim HJ
Am J Clin Oncol; 2009 Aug; 32(4):348-52. PubMed ID: 19363436
[TBL] [Abstract][Full Text] [Related]
10. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V;
Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.
Louvet C; Labianca R; Hammel P; Lledo G; Zampino MG; André T; Zaniboni A; Ducreux M; Aitini E; Taïeb J; Faroux R; Lepere C; de Gramont A; ;
J Clin Oncol; 2005 May; 23(15):3509-16. PubMed ID: 15908661
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting.
Lim KH; Kim TY; Lee KH; Han SW; Oh DY; Im SA; Kim TY; Bang YJ
Cancer Chemother Pharmacol; 2011 Oct; 68(4):1017-26. PubMed ID: 21327930
[TBL] [Abstract][Full Text] [Related]
13. Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols.
Vogl TJ; Gruber T; Naguib NN; Hammerstingl R; Nour-Eldin NE
AJR Am J Roentgenol; 2009 Oct; 193(4):941-7. PubMed ID: 19770314
[TBL] [Abstract][Full Text] [Related]
14. Continuous transarterial infusion chemotherapy with gemcitabine and 5-Fluorouracil for advanced pancreatic carcinoma.
Hong GB; Zhou JX; Sun HB; Li CY; Song LQ
Asian Pac J Cancer Prev; 2012; 13(6):2669-73. PubMed ID: 22938439
[TBL] [Abstract][Full Text] [Related]
15. Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin?
Stemmler J; Stieber P; Szymala AM; Schalhorn A; Schermuly MM; Wilkowski R; Helmberger T; Lamerz R; Stoffregen C; Niebler K; Garbrecht M; Heinemann V
Onkologie; 2003 Oct; 26(5):462-7. PubMed ID: 14605463
[TBL] [Abstract][Full Text] [Related]
16. Phase II study on combined intravenous and intra-arterial chemotherapy with gemcitabine and mitomycin C in patients with advanced pancreatic cancer.
Heinrich S; Kraft D; Staib-Sebler E; Schwarz W; Gog C; Vogl T; Lorenz M
Hepatogastroenterology; 2013 Sep; 60(126):1492-6. PubMed ID: 23933944
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas.
Feliu J; Mel R; Borrega P; López Gómez L; Escudero P; Dorta J; Castro J; Vázquez-Estévez SE; Bolaños M; Espinosa E; González Barón M;
Ann Oncol; 2002 Nov; 13(11):1756-62. PubMed ID: 12419748
[TBL] [Abstract][Full Text] [Related]
18. Intraarterial chemotherapy with gemcitabine and cisplatin in locally advanced or recurrent penile squamous cell carcinoma.
Liu JY; Li YH; Liu ZW; Zhang ZL; Ye YL; Yao K; Han H; Qin ZK; Zhou FJ
Chin J Cancer; 2013 Nov; 32(11):619-23. PubMed ID: 23668929
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine and mitomycin C in advanced pancreatic cancer: a single-institution experience.
Tuinmann G; Hegewisch-Becker S; Zschaber R; Kehr A; Schulz J; Hossfeld DK
Anticancer Drugs; 2004 Jul; 15(6):575-9. PubMed ID: 15205599
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer.
Brodowicz T; Wolfram RM; Köstler WJ; Tomek S; Vaclavik I; Steger GG; Teleky B; Függer R; Jakesz R; Zielinski CC
Anticancer Drugs; 2000 Sep; 11(8):623-8. PubMed ID: 11081453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
